TY - JOUR AU - Duarte, S. AU - Carle, G. AU - Faneca, H. AU - Lima, M. C. AU - Pierrefite-Carle, V. PY - 2012 DA - 2012// TI - Suicide gene therapy in cancer: where do we stand now? JO - Cancer Lett VL - 324 ID - Duarte2012 ER - TY - JOUR AU - Sverdlov, E. D. PY - 2011 DA - 2011// TI - Genetic surgery - a right strategy to attack cancer JO - Curr Gene Ther VL - 11 ID - Sverdlov2011 ER - TY - JOUR AU - Corti, A. AU - Pastorino, F. AU - Curnis, F. AU - Arap, W. AU - Ponzoni, M. AU - Pasqualini, R. PY - 2011 DA - 2011// TI - Targeted drug delivery and penetration into solid tumors JO - Med Res Rev VL - 32 ID - Corti2011 ER - TY - JOUR AU - Kwon, I. K. AU - Lee, S. C. AU - Han, B. AU - Park, K. PY - 2012 DA - 2012// TI - Analysis on the current status of targeted drug delivery to tumors JO - J Control Release VL - 164 ID - Kwon2012 ER - TY - JOUR AU - Ranganathan, R. AU - Madanmohan, S. AU - Kesavan, A. AU - Baskar, G. AU - Krishnamoorthy, Y. R. AU - Santosham, R. PY - 2012 DA - 2012// TI - Nanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications JO - Int J Nanomedicine VL - 7 ID - Ranganathan2012 ER - TY - JOUR AU - Li, J. AU - Chen, F. AU - Cona, M. M. AU - Feng, Y. AU - Himmelreich, U. AU - Oyen, R. PY - 2012 DA - 2012// TI - A review on various targeted anticancer therapies JO - Target Oncol VL - 7 ID - Li2012 ER - TY - JOUR AU - Collins, S. A. AU - Guinn, B. A. AU - Harrison, P. T. AU - Scallan, M. F. AU - O’Sullivan, G. C. AU - Tangney, M. PY - 2008 DA - 2008// TI - Viral vectors in cancer immunotherapy: which vector for which strategy? JO - Curr Gene Ther VL - 8 ID - Collins2008 ER - TY - JOUR AU - Loisel-Meyer, S. AU - Foley, R. AU - Medin, J. A. PY - 2008 DA - 2008// TI - Immuno-gene therapy approaches for cancer: from in vitro studies to clinical trials JO - Front Biosci VL - 13 ID - Loisel-Meyer2008 ER - TY - JOUR AU - Podhajcer, O. L. AU - Lopez, M. V. AU - Mazzolini, G. PY - 2007 DA - 2007// TI - Cytokine gene transfer for cancer therapy JO - Cytokine Growth Factor Rev VL - 18 ID - Podhajcer2007 ER - TY - JOUR AU - Brenner, M. K. AU - Okur, F. V. PY - 2009 DA - 2009// TI - Overview of gene therapy clinical progress including cancer treatment with gene-modified T cells JO - Hematology Am Soc Hematol Educ Program VL - 2009 ID - Brenner2009 ER - TY - JOUR AU - Dougan, M. AU - Dranoff, G. PY - 2009 DA - 2009// TI - Immune therapy for cancer JO - Annu Rev Immunol VL - 27 ID - Dougan2009 ER - TY - JOUR AU - Vachani, A. AU - Moon, E. AU - Wakeam, E. AU - Haas, A. R. AU - Sterman, D. H. AU - Albelda, S. M. PY - 2011 DA - 2011// TI - Gene therapy for lung neoplasms JO - Clin Chest Med VL - 32 ID - Vachani2011 ER - TY - JOUR AU - McCormick, F. PY - 2001 DA - 2001// TI - Cancer gene therapy: fringe or cutting edge? JO - Nat Rev Cancer VL - 1 ID - McCormick2001 ER - TY - JOUR AU - Ardiani, A. AU - Johnson, A. J. AU - Ruan, H. AU - Sanchez-Bonilla, M. AU - Serve, K. AU - Black, M. E. PY - 2012 DA - 2012// TI - Enzymes to die for: exploiting nucleotide metabolizing enzymes for cancer gene therapy JO - Curr Gene Ther VL - 12 ID - Ardiani2012 ER - TY - JOUR AU - Xu, J. AU - Jin, C. AU - Hao, S. AU - Luo, G. AU - Fu, D. PY - 2010 DA - 2010// TI - Pancreatic cancer: gene therapy approaches and gene delivery systems JO - Expert Opin Biol Ther VL - 10 ID - Xu2010 ER - TY - JOUR AU - Hattori, Y. PY - 2010 DA - 2010// TI - Development of nonviral vector for cancer gene therapy JO - Yakugaku Zasshi VL - 130 ID - Hattori2010 ER - TY - JOUR AU - Zarogoulidis, P. AU - Darwiche, K. AU - Sakkas, A. AU - Yarmus, L. AU - Huang, H. AU - Li, Q. PY - 2013 DA - 2013// TI - Suicide gene therapy for cancer - current strategies JO - J Genet Syndr Gene Ther VL - 4 ID - Zarogoulidis2013 ER - TY - JOUR AU - Malecki, M. PY - 2012 DA - 2012// TI - Frontiers in suicide gene therapy of cancer JO - J Genet Syndr Gene Ther VL - 3 ID - Malecki2012 ER - TY - JOUR AU - Portsmouth, D. AU - Hlavaty, J. AU - Renner, M. PY - 2007 DA - 2007// TI - Suicide genes for cancer therapy JO - Mol Aspects Med VL - 28 ID - Portsmouth2007 ER - TY - JOUR AU - Dillen, I. J. AU - Mulder, N. H. AU - Vaalburg, W. AU - Vries, E. F. AU - Hospers, G. A. PY - 2002 DA - 2002// TI - Influence of the bystander effect on HSV-tk/GCV gene therapy JO - A review Curr Gene Ther VL - 2 ID - Dillen2002 ER - TY - JOUR AU - Mesnil, M. AU - Yamasaki, H. PY - 2000 DA - 2000// TI - Bystander effect in herpes simplex virus-thymidine kinase/ganciclovir cancer gene therapy: role of gap-junctional intercellular communication JO - Cancer Res VL - 60 ID - Mesnil2000 ER - TY - JOUR AU - Dachs, G. U. AU - Hunt, M. A. AU - Syddall, S. AU - Singleton, D. C. AU - Patterson, A. V. PY - 2009 DA - 2009// TI - Bystander or no bystander for gene directed enzyme prodrug therapy JO - Molecules VL - 14 ID - Dachs2009 ER - TY - JOUR AU - Khatri, A. AU - Zhang, B. AU - Doherty, E. AU - Chapman, J. AU - Ow, K. AU - Pwint, H. PY - 2006 DA - 2006// TI - Combination of cytosine deaminase with uracil phosphoribosyl transferase leads to local and distant bystander effects against RM1 prostate cancer in mice JO - J Gene Med VL - 8 ID - Khatri2006 ER - TY - JOUR AU - Preuss, E. AU - Muik, A. AU - Weber, K. AU - Otte, J. AU - Laer, D. AU - Fehse, B. PY - 2011 DA - 2011// TI - Cancer suicide gene therapy with TK.007: superior killing efficiency and bystander effect JO - J Mol Med (Berl) VL - 89 ID - Preuss2011 ER - TY - CHAP AU - Slavcev, R. AU - Wettig, S. AU - Kaur, T. ED - Yuan, X. PY - 2011 DA - 2011// TI - Nanomedicine based approaches to cancer diagonsis and therapy, nonviral gene therapy BT - Nonviral gene therapy PB - InTech Open Access Publisher CY - Rijeka, Croatia ID - Slavcev2011 ER - TY - JOUR AU - Cerullo, V. AU - Pesonen, S. AU - Diaconu, I. AU - Escutenaire, S. AU - Arstila, P. T. AU - Ugolini, M. PY - 2010 DA - 2010// TI - Oncolytic adenovirus coding for granulocyte macrophage colony-stimulating factor induces antitumoral immunity in cancer patients JO - Cancer Res VL - 70 ID - Cerullo2010 ER - TY - JOUR AU - Niculescu-Duvaz, I. AU - Springer, C. J. PY - 2005 DA - 2005// TI - Introduction to the background, principles, and state of the art in suicide gene therapy JO - Mol Biotechnol VL - 30 ID - Niculescu-Duvaz2005 ER - TY - JOUR AU - Candido, J. AU - Hagemann, T. PY - 2013 DA - 2013// TI - Cancer-related inflammation JO - J Clin Immunol VL - 33 ID - Candido2013 ER - TY - JOUR AU - Hallett, M. A. AU - Venmar, K. T. AU - Fingleton, B. PY - 2012 DA - 2012// TI - Cytokine stimulation of epithelial cancer cells: the similar and divergent functions of IL-4 and IL-13 JO - Cancer Res VL - 72 ID - Hallett2012 ER - TY - JOUR AU - Berzofsky, J. A. AU - Terabe, M. AU - Wood, L. V. PY - 2012 DA - 2012// TI - Strategies to use immune modulators in therapeutic vaccines against cancer JO - Semin Oncol VL - 39 ID - Berzofsky2012 ER - TY - JOUR AU - Pesonen, S. AU - Kangasniemi, L. AU - Hemminki, A. PY - 2011 DA - 2011// TI - Oncolytic adenoviruses for the treatment of human cancer: focus on translational and clinical data JO - Mol Pharm VL - 8 ID - Pesonen2011 ER - TY - JOUR AU - Grossardt, C. AU - Engeland, C. E. AU - Bossow, S. AU - Halama, N. AU - Zaoui, K. AU - Leber, M. F. PY - 2013 DA - 2013// TI - Granulocyte-macrophage colony-stimulating factor-armed oncolytic measles virus is an effective therapeutic cancer vaccine JO - Hum Gene Ther VL - 24 ID - Grossardt2013 ER - TY - JOUR AU - Burke, J. M. AU - Lamm, D. L. AU - Meng, M. V. AU - Nemunaitis, J. J. AU - Stephenson, J. J. AU - Arseneau, J. C. PY - 2012 DA - 2012// TI - A first in human phase 1 study of CG0070, a GM-CSF expressing oncolytic adenovirus, for the treatment of nonmuscle invasive bladder cancer JO - J Urol VL - 188 ID - Burke2012 ER - TY - JOUR AU - Senzer, N. N. AU - Kaufman, H. L. AU - Amatruda, T. AU - Nemunaitis, M. AU - Reid, T. AU - Daniels, G. PY - 2009 DA - 2009// TI - Phase II clinical trial of a granulocyte-macrophage colony-stimulating factor-encoding, second-generation oncolytic herpesvirus in patients with unresectable metastatic melanoma JO - J Clin Oncol VL - 27 ID - Senzer2009 ER - TY - JOUR AU - Hu, J. C. AU - Coffin, R. S. AU - Davis, C. J. AU - Graham, N. J. AU - Groves, N. AU - Guest, P. J. PY - 2006 DA - 2006// TI - A phase I study of OncoVEXGM-CSF, a second-generation oncolytic herpes simplex virus expressing granulocyte macrophage colony-stimulating factor JO - Clin Cancer Res VL - 12 ID - Hu2006 ER - TY - JOUR AU - Gupta, R. AU - Emens, L. A. PY - 2010 DA - 2010// TI - GM-CSF-secreting vaccines for solid tumors: moving forward JO - Discov Med VL - 10 ID - Gupta2010 ER - TY - JOUR AU - Vacchelli, E. AU - Galluzzi, L. AU - Eggermont, A. AU - Galon, J. AU - Tartour, E. AU - Zitvogel, L. PY - 2012 DA - 2012// TI - Trial watch: immunostimulatory cytokines JO - Oncoimmunology VL - 1 ID - Vacchelli2012 ER - TY - JOUR AU - Zhang, S. N. AU - Choi, I. K. AU - Huang, J. H. AU - Yoo, J. Y. AU - Choi, K. J. AU - Yun, C. O. PY - 2011 DA - 2011// TI - Optimizing DC vaccination by combination with oncolytic adenovirus coexpressing IL-12 and GM-CSF JO - Mol Ther VL - 19 ID - Zhang2011 ER - TY - JOUR AU - Brockstedt, D. G. AU - Diagana, M. AU - Zhang, Y. AU - Tran, K. AU - Belmar, N. AU - Meier, M. PY - 2002 DA - 2002// TI - Development of anti-tumor immunity against a non-immunogenic mammary carcinoma through in vivo somatic GM-CSF, IL-2, and HSVtk combination gene therapy JO - Mol Ther VL - 6 ID - Brockstedt2002 ER - TY - JOUR AU - Majumdar, A. S. AU - Zolotorev, A. AU - Samuel, S. AU - Tran, K. AU - Vertin, B. AU - Hall-Meier, M. PY - 2000 DA - 2000// TI - Efficacy of herpes simplex virus thymidine kinase in combination with cytokine gene therapy in an experimental metastatic breast cancer model JO - Cancer Gene Ther VL - 7 ID - Majumdar2000 ER - TY - JOUR AU - Jones, R. K. AU - Pope, I. M. AU - Kinsella, A. R. AU - Watson, A. J. AU - Christmas, S. E. PY - 2000 DA - 2000// TI - Combined suicide and granulocyte-macrophage colony-stimulating factor gene therapy induces complete tumor regression and generates antitumor immunity JO - Cancer Gene Ther VL - 7 ID - Jones2000 ER - TY - JOUR AU - Lee, K. H. AU - Piao, H. AU - Son, B. R. AU - Heo, D. S. AU - Kim, N. K. AU - Kim, S. T. PY - 2004 DA - 2004// TI - Herpes simplex virus thymidine kinase and granulocyte macrophage colony-stimulating factor combination gene therapy in a murine CT26 cell colon cancer model JO - Cancer Gene Ther VL - 11 ID - Lee2004 ER - TY - JOUR AU - Ostrand-Rosenberg, S. AU - Sinha, P. AU - Beury, D. W. AU - Clements, V. K. PY - 2012 DA - 2012// TI - Cross-talk between Myeloid-Derived Suppressor Cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression JO - Semin Cancer Biol VL - 22 ID - Ostrand-Rosenberg2012 ER - TY - JOUR AU - Lu, T. AU - Gabrilovich, D. I. PY - 2012 DA - 2012// TI - Molecular pathways: tumor-infiltrating myeloid cells and reactive oxygen species in regulation of tumor microenvironment JO - Clin Cancer Res VL - 18 ID - Lu2012 ER - TY - JOUR AU - Kao, J. AU - Ko, E. C. AU - Eisenstein, S. AU - Sikora, A. G. AU - Fu, S. AU - Chen, S. H. PY - 2011 DA - 2011// TI - Targeting immune suppressing myeloid-derived suppressor cells in oncology JO - Crit Rev Oncol Hematol VL - 77 ID - Kao2011 ER - TY - JOUR AU - Bayne, L. J. AU - Beatty, G. L. AU - Jhala, N. AU - Clark, C. E. AU - Rhim, A. D. AU - Stanger, B. Z. PY - 2012 DA - 2012// TI - Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer JO - Cancer Cell VL - 21 ID - Bayne2012 ER - TY - JOUR AU - Gutschalk, C. M. AU - Yanamandra, A. K. AU - Linde, N. AU - Meides, A. AU - Depner, S. AU - Mueller, M. M. PY - 2013 DA - 2013// TI - GM-CSF enhances tumor invasion by elevated MMP-2, −9, and −26 expression JO - Cancer Med VL - 2 ID - Gutschalk2013 ER - TY - JOUR AU - Pylayeva-Gupta, Y. AU - Lee, K. E. AU - Hajdu, C. H. AU - Miller, G. AU - Bar-Sagi, D. PY - 2012 DA - 2012// TI - Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia JO - Cancer Cell VL - 21 ID - Pylayeva-Gupta2012 ER - TY - JOUR AU - Parato, K. A. AU - Breitbach, C. J. AU - Boeuf, F. AU - Wang, J. AU - Storbeck, C. AU - Ilkow, C. PY - 2012 DA - 2012// TI - The oncolytic poxvirus JX-594 selectively replicates in and destroys cancer cells driven by genetic pathways commonly activated in cancers JO - Mol Ther VL - 20 ID - Parato2012 ER - TY - JOUR AU - Kim, J. H. AU - Oh, J. Y. AU - Park, B. H. AU - Lee, D. E. AU - Kim, J. S. AU - Park, H. E. PY - 2006 DA - 2006// TI - Systemic armed oncolytic and immunologic therapy for cancer with JX-594, a targeted poxvirus expressing GM-CSF JO - Mol Ther VL - 14 ID - Kim2006 ER - TY - JOUR AU - Lei, N. AU - Shen, F. B. AU - Chang, J. H. AU - Wang, L. AU - Li, H. AU - Yang, C. PY - 2009 DA - 2009// TI - An oncolytic adenovirus expressing granulocyte macrophage colony-stimulating factor shows improved specificity and efficacy for treating human solid tumors JO - Cancer Gene Ther VL - 16 ID - Lei2009 ER - TY - JOUR AU - Lee, J. H. AU - Roh, M. S. AU - Lee, Y. K. AU - Kim, M. K. AU - Han, J. Y. AU - Park, B. H. PY - 2009 DA - 2009// TI - Oncolytic and immunostimulatory efficacy of a targeted oncolytic poxvirus expressing human GM-CSF following intravenous administration in a rabbit tumor model JO - Cancer Gene Ther VL - 2 ID - Lee2009 ER - TY - JOUR AU - Malhotra, S. AU - Kim, T. AU - Zager, J. AU - Bennett, J. AU - Ebright, M. AU - D’Angelica, M. PY - 2007 DA - 2007// TI - Use of an oncolytic virus secreting GM-CSF as combined oncolytic and immunotherapy for treatment of colorectal and hepatic adenocarcinomas JO - Surgery VL - 141 ID - Malhotra2007 ER - TY - JOUR AU - Kanerva, A. AU - Nokisalmi, P. AU - Diaconu, I. AU - Koski, A. AU - Cerullo, V. AU - Liikanen, I. PY - 2013 DA - 2013// TI - Antiviral and antitumor T-cell immunity in patients treated with GM-CSF-coding oncolytic adenovirus JO - Clin Cancer Res VL - 19 ID - Kanerva2013 ER - TY - JOUR AU - Prestwich, R. J. AU - Errington, F. AU - Harrington, K. J. AU - Pandha, H. S. AU - Selby, P. AU - Melcher, A. PY - 2008 DA - 2008// TI - Oncolytic viruses: do they have a role in anti-cancer therapy? JO - Clinical Medicine oncology VL - 2008 ID - Prestwich2008 ER - TY - JOUR AU - Yue, Y. AU - Wu, C. PY - 2013 DA - 2013// TI - Progress and perspectives in developing polymeric vectors for in vitro gene delivery JO - Biomaterials Science VL - 1 ID - Yue2013 ER - TY - JOUR AU - Ulasov, A. V. AU - Khramtsov, Y. V. AU - Trusov, G. A. AU - Rosenkranz, A. A. AU - Sverdlov, E. D. AU - Sobolev, A. S. PY - 2011 DA - 2011// TI - Properties of PEI-based polyplex nanoparticles that correlate with their transfection efficacy JO - Mol Ther VL - 19 ID - Ulasov2011 ER - TY - JOUR AU - Mityaev, M. V. AU - Kopantzev, E. P. AU - Buzdin, A. A. AU - Vinogradova, T. V. AU - Sverdlov, E. D. PY - 2008 DA - 2008// TI - Functional significance of a putative sp1 transcription factor binding site in the survivin gene promoter JO - Biochemistry (Mosc) VL - 73 ID - Mityaev2008 ER - TY - JOUR AU - Alekseenko, I. V. AU - Kopantzev, E. P. AU - Vinogradova, T. V. AU - Sverdlov, E. D. PY - 2011 DA - 2011// TI - Bicistronic vector for combined expression of the HSVtk killer gene and cytokine GM-CSF gene in cancer cells JO - Dokl Biochem Biophys VL - 439 ID - Alekseenko2011 ER - TY - JOUR AU - Kitamura, T. AU - Tange, T. AU - Terasawa, T. AU - Chiba, S. AU - Kuwaki, T. AU - Miyagawa, K. PY - 1989 DA - 1989// TI - Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin JO - J Cell Physiol VL - 140 ID - Kitamura1989 ER - TY - JOUR AU - Inaba, K. AU - Inaba, M. AU - Romani, N. AU - Aya, H. AU - Deguchi, M. AU - Ikehara, S. PY - 1992 DA - 1992// TI - Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor JO - J Exp Med VL - 176 ID - Inaba1992 ER - TY - BOOK AU - Mironov, A. AU - Bunatian, N. AU - Vasyliev, A. AU - Varstakova, O. AU - Zhuravleva, M. AU - Lepahin, V. PY - 2012 DA - 2012// TI - Guidelines for conducting preclinical tests of pharmaceuticals PB - Co Publisher CY - Moscow, Russia; Part One ID - Mironov2012 ER - TY - JOUR AU - Rudolph, C. AU - Plank, C. AU - Lausier, J. AU - Schillinger, U. AU - Muller, R. H. AU - Rosenecker, J. PY - 2003 DA - 2003// TI - Oligomers of the arginine-rich motif of the HIV-1 TAT protein are capable of transferring plasmid DNA into cells JO - J Biol Chem VL - 278 ID - Rudolph2003 ER - TY - JOUR AU - Castleden, S. A. AU - Chong, H. AU - Garcia-Ribas, I. AU - Melcher, A. A. AU - Hutchinson, G. AU - Roberts, B. PY - 1997 DA - 1997// TI - A family of bicistronic vectors to enhance both local and systemic antitumor effects of HSVtk or cytokine expression in a murine melanoma model JO - Hum Gene Ther VL - 8 ID - Castleden1997 ER - TY - JOUR AU - Kleemann, E. AU - Neu, M. AU - Jekel, N. AU - Fink, L. AU - Schmehl, T. AU - Gessler, T. PY - 2005 DA - 2005// TI - Nano-carriers for DNA delivery to the lung based upon a TAT-derived peptide covalently coupled to PEG-PEI JO - J Control Release VL - 109 ID - Kleemann2005 ER - TY - JOUR AU - Wang, Y. AU - Xu, H. X. AU - Lu, M. D. AU - Tang, Q. PY - 2008 DA - 2008// TI - Expression of thymidine kinase mediated by a novel nonviral delivery system under the control of vascular endothelial growth factor receptor 2 promoter selectively kills human umbilical vein endothelial cells JO - World J Gastroenterol VL - 14 ID - Wang2008 ER - TY - JOUR AU - Robles, A. I. AU - Varticovski, L. PY - 2008 DA - 2008// TI - Harnessing genetically engineered mouse models for preclinical testing JO - Chem Biol Interact VL - 171 ID - Robles2008 ER - TY - JOUR AU - Singh, M. AU - Murriel, C. L. AU - Johnson, L. PY - 2012 DA - 2012// TI - Genetically engineered mouse models: closing the gap between preclinical data and trial outcomes JO - Cancer Res VL - 72 ID - Singh2012 ER - TY - JOUR AU - Dachs, G. U. AU - Tupper, J. AU - Tozer, G. M. PY - 2005 DA - 2005// TI - From bench to bedside for gene-directed enzyme prodrug therapy of cancer JO - Anticancer Drugs VL - 16 ID - Dachs2005 ER - TY - JOUR AU - Gagandeep, S. AU - Brew, R. AU - Green, B. AU - Christmas, S. E. AU - Klatzmann, D. AU - Poston, G. J. PY - 1996 DA - 1996// TI - Prodrug-activated gene therapy: involvement of an immunological component in the “bystander effect” JO - Cancer Gene Ther VL - 3 ID - Gagandeep1996 ER - TY - JOUR AU - Fillat, C. AU - Carrio, M. AU - Cascante, A. AU - Sangro, B. PY - 2003 DA - 2003// TI - Suicide gene therapy mediated by the Herpes Simplex virus thymidine kinase gene/Ganciclovir system: fifteen years of application JO - Curr Gene Ther VL - 3 ID - Fillat2003 ER - TY - JOUR AU - Kwiatkowska, A. AU - Nandhu, M. S. AU - Behera, P. AU - Chiocca, E. A. AU - Viapiano, M. S. PY - 2013 DA - 2013// TI - Strategies in gene therapy for glioblastoma JO - Cancers (Basel) VL - 5 ID - Kwiatkowska2013 ER - TY - JOUR AU - Ginn, S. L. AU - Alexander, I. E. AU - Edelstein, M. L. AU - Abedi, M. R. AU - Wixon, J. PY - 2013 DA - 2013// TI - Gene therapy clinical trials worldwide to 2012 - an update JO - J Gene Med VL - 15 ID - Ginn2013 ER - TY - JOUR AU - Rangarajan, A. AU - Weinberg, R. A. PY - 2003 DA - 2003// TI - Opinion: comparative biology of mouse versus human cells: modelling human cancer in mice JO - Nat Rev Cancer VL - 3 ID - Rangarajan2003 ER - TY - JOUR AU - Greek, R. AU - Menache, A. PY - 2013 DA - 2013// TI - Systematic reviews of animal models: methodology versus epistemology JO - Int J Med Sci VL - 10 ID - Greek2013 ER - TY - JOUR AU - Greek, R. AU - Hansen, L. A. PY - 2013 DA - 2013// TI - Questions regarding the predictive value of one evolved complex adaptive system for a second: exemplified by the SOD1 mouse JO - Prog Biophys Mol Biol VL - 113 ID - Greek2013 ER - TY - JOUR AU - Lammers, T. AU - Kiessling, F. AU - Hennink, W. E. AU - Storm, G. PY - 2012 DA - 2012// TI - Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress JO - J Control Release VL - 161 ID - Lammers2012 ER - TY - JOUR AU - Maeda, H. AU - Nakamura, H. AU - Fang, J. PY - 2013 DA - 2013// TI - The EPR effect for macromolecular drug delivery to solid tumors: improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo JO - Adv Drug Deliv Rev VL - 65 ID - Maeda2013 ER - TY - JOUR AU - Fang, J. AU - Nakamura, H. AU - Maeda, H. PY - 2011 DA - 2011// TI - The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect JO - Adv Drug Deliv Rev VL - 63 ID - Fang2011 ER - TY - JOUR AU - Prabhakar, U. AU - Maeda, H. AU - Jain, R. K. AU - Sevick-Muraca, E. M. AU - Zamboni, W. AU - Farokhzad, O. C. PY - 2013 DA - 2013// TI - Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology JO - Cancer Res VL - 73 ID - Prabhakar2013 ER - TY - JOUR AU - Durymanov, M. O. AU - Slastnikova, T. A. AU - Kuzmich, A. I. AU - Khramtsov, Y. V. AU - Ulasov, A. V. AU - Rosenkranz, A. A. PY - 2013 DA - 2013// TI - Microdistribution of MC1R-targeted polyplexes in murine melanoma tumor tissue JO - Biomaterials VL - 34 ID - Durymanov2013 ER - TY - JOUR AU - Zhang, T. AU - Hamada, K. AU - Hyodo, M. AU - Itoh, H. AU - Tani, K. AU - Goda, H. PY - 2011 DA - 2011// TI - Gene therapy for oral squamous cell carcinoma with IAI.3B promoter-driven oncolytic adenovirus-infected carrier cells JO - Oncol Rep VL - 25 ID - Zhang2011 ER - TY - JOUR AU - Vanneman, M. AU - Dranoff, G. PY - 2012 DA - 2012// TI - Combining immunotherapy and targeted therapies in cancer treatment JO - Nat Rev Cancer VL - 12 ID - Vanneman2012 ER - TY - JOUR AU - Wei, F. AU - Wang, H. AU - Zhang, J. AU - Chen, X. AU - Li, C. AU - Huang, Q. PY - 2013 DA - 2013// TI - Pharmacokinetics of combined gene therapy expressing constitutive human GM-CSF and hyperthermia-regulated human IL-12 JO - J Exp Clin Cancer Res VL - 32 ID - Wei2013 ER - TY - STD TI - Gene therapy. Clinical trials worldwide. J Gene Med. 2014 [http://www.wiley.com//legacy/wileychi/genmed/clinical] UR - http://www.wiley.com//legacy/wileychi/genmed/clinical ID - ref85 ER - TY - JOUR AU - Zhou, Y. AU - Kopecek, J. PY - 2013 DA - 2013// TI - Biological rationale for the design of polymeric anti-cancer nanomedicines JO - J Drug Target VL - 21 ID - Zhou2013 ER - TY - JOUR AU - Rosel, D. AU - Brabek, J. AU - Vesely, P. AU - Fernandes, M. PY - 2013 DA - 2013// TI - Drugs for solid cancer: the productivity crisis prompts a rethink JO - Onco Targets Ther VL - 6 ID - Rosel2013 ER - TY - JOUR AU - Tuting, T. PY - 2012 DA - 2012// TI - T cell immunotherapy for melanoma from bedside to bench to barn and back: how conceptual advances in experimental mouse models can be translated into clinical benefit for patients JO - Pigment Cell Melanoma Res VL - 26 ID - Tuting2012 ER - TY - JOUR AU - Thorne, S. H. PY - 2013 DA - 2013// TI - The role of GM-CSF in enhancing immunotherapy of cancer JO - Immunotherapy VL - 5 ID - Thorne2013 ER - TY - JOUR AU - Pesonen, S. AU - Diaconu, I. AU - Cerullo, V. AU - Escutenaire, S. AU - Raki, M. AU - Kangasniemi, L. PY - 2012 DA - 2012// TI - Integrin targeted oncolytic adenoviruses Ad5-D24-RGD and Ad5-RGD-D24-GMCSF for treatment of patients with advanced chemotherapy refractory solid tumors JO - Int J Cancer VL - 130 ID - Pesonen2012 ER - TY - JOUR AU - Jang, S. H. AU - Wientjes, M. G. AU - Lu, D. AU - Au, J. L. PY - 2003 DA - 2003// TI - Drug delivery and transport to solid tumors JO - Pharm Res VL - 20 ID - Jang2003 ER - TY - JOUR AU - Lankelma, J. AU - Dekker, H. AU - Luque, F. R. AU - Luykx, S. AU - Hoekman, K. AU - Valk, P. PY - 1999 DA - 1999// TI - Doxorubicin gradients in human breast cancer JO - Clin Cancer Res VL - 5 ID - Lankelma1999 ER - TY - JOUR AU - Tredan, O. AU - Galmarini, C. M. AU - Patel, K. AU - Tannock, I. F. PY - 2007 DA - 2007// TI - Drug resistance and the solid tumor microenvironment JO - J Natl Cancer Inst VL - 99 ID - Tredan2007 ER - TY - JOUR AU - Tannock, I. F. AU - Lee, C. M. AU - Tunggal, J. K. AU - Cowan, D. S. AU - Egorin, M. J. PY - 2002 DA - 2002// TI - Limited penetration of anticancer drugs through tumor tissue: a potential cause of resistance of solid tumors to chemotherapy JO - Clin Cancer Res VL - 8 ID - Tannock2002 ER - TY - JOUR AU - Kyle, A. H. AU - Huxham, L. A. AU - Yeoman, D. M. AU - Minchinton, A. I. PY - 2007 DA - 2007// TI - Limited tissue penetration of taxanes: a mechanism for resistance in solid tumors JO - Clin Cancer Res VL - 13 ID - Kyle2007 ER - TY - JOUR AU - Hambley, T. W. AU - Hait, W. N. PY - 2009 DA - 2009// TI - Is anticancer drug development heading in the right direction? JO - Cancer Res VL - 69 ID - Hambley2009 ER - TY - JOUR AU - Flotte, T. R. PY - 2007 DA - 2007// TI - Gene therapy: the first two decades and the current state-of-the-art JO - J Cell Physiol VL - 213 ID - Flotte2007 ER - TY - JOUR AU - Ohlfest, J. R. AU - Freese, A. B. AU - Largaespada, D. A. PY - 2005 DA - 2005// TI - Nonviral vectors for cancer gene therapy: prospects for integrating vectors and combination therapies JO - Curr Gene Ther VL - 5 ID - Ohlfest2005 ER - TY - JOUR AU - Templeton, N. S. PY - 2009 DA - 2009// TI - Nonviral delivery for genomic therapy of cancer JO - World J Surg VL - 33 ID - Templeton2009 ER - TY - JOUR AU - Zhang, Y. AU - Satterlee, A. AU - Huang, L. PY - 2012 DA - 2012// TI - In vivo gene delivery by nonviral vectors: overcoming hurdles? JO - Mol Ther VL - 20 ID - Zhang2012 ER - TY - JOUR AU - Lee, W. Y. AU - Zhang, T. AU - Lau, C. P. AU - Wang, C. C. AU - Chan, K. M. AU - Li, G. PY - 2013 DA - 2013// TI - Immortalized human fetal bone marrow-derived mesenchymal stromal cell expressing suicide gene for anti-tumor therapy in vitro and in vivo JO - Cytotherapy VL - 15 ID - Lee2013 ER - TY - JOUR AU - Altaner, C. PY - 2008 DA - 2008// TI - Prodrug cancer gene therapy JO - Cancer Lett VL - 270 ID - Altaner2008 ER - TY - JOUR AU - Seth, P. PY - 2005 DA - 2005// TI - Vector-mediated cancer gene therapy: an overview JO - Cancer Biol Ther VL - 4 ID - Seth2005 ER - TY - JOUR AU - Halama, A. AU - Kulinski, M. AU - Librowski, T. AU - Lochynski, S. PY - 2009 DA - 2009// TI - Polymer-based nonviral gene delivery as a concept for the treatment of cancer JO - Pharmacol Rep VL - 61 ID - Halama2009 ER - TY - JOUR AU - Lam, P. AU - Khan, G. AU - Stripecke, R. AU - Hui, K. M. AU - Kasahara, N. AU - Peng, K. W. PY - 2013 DA - 2013// TI - The innovative evolution of cancer gene and cellular therapies JO - Cancer Gene Ther VL - 20 ID - Lam2013 ER - TY - JOUR AU - Louise, C. PY - 2006 DA - 2006// TI - Nonviral vectors JO - Methods Mol Biol VL - 333 ID - Louise2006 ER - TY - JOUR AU - Duenas-Gonzalez, A. AU - Garcia-Lopez, P. AU - Herrera, L. A. AU - Medina-Franco, J. L. AU - Gonzalez-Fierro, A. AU - Candelaria, M. PY - 2008 DA - 2008// TI - The prince and the pauper. A tale of anticancer targeted agents JO - Mol Cancer VL - 7 ID - Duenas-Gonzalez2008 ER -